Blanck Ronald R

Avg. Two Year Performance

(32%) Avg. Purchase Return
(15%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(7%)(10%)(11%)(41%)(32%)
Purchase Success Rate0 of 40 of 41 of 40 of 40 of 4
Average Sale Return(9%)17%21%50%0%
Sale Success Rate0 of 11 of 11 of 11 of 10 of 1

Carrington Laboratories Inc.

Other » Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Tenax Therapeutics, Inc.

Drugs » Biotechnology

Director:

Holdings: 6.06K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--